Kyoto Prefectural University of Medicine at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Kyoto Prefectural University of Medicine brings 3 presentations to ESGCT 2026 in Hamburg. Its work centres on genome editing delivered in the body, including a base editor packaged in a single AAV to correct inherited retinal degeneration. Other strands edit PCSK9 with a compact Cas enzyme and install a protective APP variant to head off Alzheimer's disease.

OrganizationESGCT 2026 Attendance
Universities & institutes
Public medical university in Kyoto, Japan.
Poster
Thu Oct 29
2:00pm–4:00pm
Single-AAV delivery of evoCas9d base editor enables therapeutic correction of inherited retinal degeneration
Gene Editing
Poster
Thu Oct 29
2:00pm–4:00pm
Therapeutic PCSK9 genome editing with engineered hypercompact Cas12j in humanized PCSK9 mice
Gene Editing
Talk
Thu Oct 29
5:30pm–6:00pm

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Kyoto Prefectural University of Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction